None listed
Conditions
Interventions
Intervention1: Test Product: Dermqure Radiant Day Serum: Test Product: Dermqure Radiant Day Serum
Dose: :2-3 drops twice a day
Route of Administration: Topical
Duration:28 days
Control Intervention1:
Sponsors
UAS Pharmaceuticals Pty Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Gender: Male and Female aged Between 25 to 55. 2. Ethnicity: Indian. 3. Fitzpatrick skin type III VI (preferred) 4. Subjects with early signs of aging. 5. Non-pregnant, non-lactating female. 6. Subjects Willing to avoid conflicting skincare products. 7. Subjects Willing to follow study instructions. 8. Subject has crow feet around the eyes. 9. Subject willing to give written informed 10. Women of child bearing potential must have a negative urine pregnancy test. 11. Free of any systemic and dermatologic disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE. 12. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
Exclusion criteria
Exclusion criteria: 1. Subjects who are pregnant, breast feeding, or planning to become pregnant during the study 2. Volunteers with skin conditions such as eczema, psoriasis 3. Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition. 4. Have open sore or open lesions in the treatment area 5. Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product. 6. Subjects participated in Recent aesthetic procedure (less than 12 weeks) 7. Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents. 8. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications (i.e., biologics), including corticosteroids. 9. Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years. 10. Subjects have use any prescription retinoids or depigmenting drugs within 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. change in Skin Hydration (Corneometer) 2. change in TEWL (Tewameter) 3. change in Skin Gloss (Glossymeter) 4. change in Skin Firmness (Cutometer Assessment) 5. Dermatological Evaluations Timepoint: Day0, Day7, Day14, Day21, Day28 | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactPuneet Mittal
CCFT Laboratories
Outcome results
None listed